Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAHONEY DAVID L −$12.3M Director sold 8% of stake
  2. Maduck Sean −$11.7M See Remarks sold 91% of stake
  3. Vieira Roberto Wandenkolk −$8.1M President, Oncology sold 95% of stake
  4. Park Kimberly −$3.3M Director sold 100% of stake
  5. Lyon Joseph Douglas −$2.3M See Remarks sold 78% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −1,606 $113.72 $183K 11,088
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −5,621 $114.58 $644K 5,467
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Sale 10b5-1 −1,225 $115.44 $141K 4,242
2026-09-02 Vieira Roberto Wandenkolk President, Oncology Option exercise · Stock option (right to buy) 10b5-1 −58,333 141,667
2026-09-02 Lyon Joseph Douglas See Remarks Shares withheld for taxes −72 $113.38 $8K 5,683
2026-09-01 Guyer William Chief Development Officer Grant or award +164 $113.38 $19K 4,149
2026-09-01 Guyer William Chief Development Officer Grant or award +164 4,313
2026-09-01 Maduck Sean See Remarks Option exercise 10b5-1 +25,000 $8.27 $207K 34,755
2026-09-01 Maduck Sean See Remarks Sale 10b5-1 −11,730 $113.94 $1.3M 23,025
2026-09-01 Maduck Sean See Remarks Sale 10b5-1 −10,989 $114.71 $1.3M 12,036
2026-09-01 Maduck Sean See Remarks Sale 10b5-1 −2,281 $115.61 $264K 9,755
2026-09-01 Maduck Sean See Remarks Grant or award 10b5-1 +150 $113.38 $17K 9,905
2026-09-01 Maduck Sean See Remarks Grant or award 10b5-1 +150 10,055
2026-09-01 Maduck Sean See Remarks Option exercise · Stock option (right to buy) 10b5-1 −25,000 66,986
2026-09-01 Mokari Atabak Chief Financial Officer Grant or award +138 $113.38 $16K 16,268
2026-09-01 Mokari Atabak Chief Financial Officer Grant or award +138 16,406
2026-09-01 Robb Gary Charles Chief Business Officer Grant or award +164 $113.38 $19K 13,590
2026-09-01 Robb Gary Charles Chief Business Officer Grant or award +164 13,754
2026-09-01 Vieira Roberto Wandenkolk President, Oncology Grant or award 10b5-1 +138 $113.38 $16K 4,206
2026-09-01 Vieira Roberto Wandenkolk President, Oncology Grant or award 10b5-1 +138 4,344

Page 4 of 50 · 995 trades